Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 9168374)

1.

The estrogen component of OCs: cardiovascular benefits and risks.

Burkman RT.

Int J Fertil Womens Med. 1997;Suppl 1:145-57. Review.

PMID:
9168374
2.

Estrogen and progestin components of oral contraceptives: relationship to vascular disease.

Carr BR, Ory H.

Contraception. 1997 May;55(5):267-72. Review.

PMID:
9220222
3.

Smoking and use of oral contraceptives: impact on thrombotic diseases.

Lidegaard O.

Am J Obstet Gynecol. 1999 Jun;180(6 Pt 2):S357-63.

PMID:
10368521
4.

[Vascular disease and hormonal treatment--epidemiology].

Vessey MP.

Contracept Fertil Sex (Paris). 1985 Jan;13(1 Suppl):121-6. French.

PMID:
12280197
5.

[Cardiovascular risks of oral contraceptives: dose-response relationship].

Kelleher CC.

Contracept Fertil Sex (Paris). 1991 Apr;19(4):285-8. French.

PMID:
12343220
6.

Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.

Mann JI.

Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):752-7.

PMID:
7065056
7.

Epidemiology of oral contraceptives and cardiovascular disease.

Chasan-Taber L, Stampfer MJ.

Ann Intern Med. 1998 Mar 15;128(6):467-77. Review.

PMID:
9499331
8.

An epidemiologic survey of cardiovascular disease in women taking oral contraceptives.

Thorogood M, Vessey MP.

Am J Obstet Gynecol. 1990 Jul;163(1 Pt 2):274-81. Review.

PMID:
2196799
9.

Oral contraceptive risks: a realistic appraisal.

Bressler R, Durand JL.

Drug Ther (NY). 1979 Oct;9(10):81-95.

PMID:
12279276
10.

The formulation of oral contraceptives: does the amount of estrogen make any clinical difference?

Speroff L.

Johns Hopkins Med J. 1982 May;150(5):170-6. Review.

PMID:
7043035
11.

Oral contraceptive use and myocardial infarction.

Petitti DB, Sidney S, Quesenberry CP.

Contraception. 1998 Mar;57(3):143-55. Review.

PMID:
9617531
12.

Oral contraceptives and vascular disease.

Sartwell PE, Stolley PD.

Epidemiol Rev. 1982;4:95-109. Review.

PMID:
6754411
13.

Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives.

Roy S.

Am J Obstet Gynecol. 1999 Jun;180(6 Pt 2):S364-8. Review.

PMID:
10368522
14.

Combined oral contraceptives, smoking, and cardiovascular risk.

Farley TM, Meirik O, Chang CL, Poulter NR.

J Epidemiol Community Health. 1998 Dec;52(12):775-85.

15.

[Combined contraceptives and cardiovascular risk].

Belaisch J, Hommais-loufrani B.

Contracept Fertil Sex (Paris). 1987 Dec;15(12 Suppl):1-8. French.

PMID:
12315199
16.

Hormonal contraception and risk of cardiovascular disease. An international perspective.

Farley TM, Collins J, Schlesselman JJ.

Contraception. 1998 Mar;57(3):211-30. Review.

PMID:
9617537
17.

Cardiovascular risks: perception versus reality.

Mishell DR Jr.

Contraception. 1999 Jan;59(1 Suppl):21S-24S. Review.

PMID:
10342092
18.

Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States.

Schwingl PJ, Ory HW, Visness CM.

Am J Obstet Gynecol. 1999 Jan;180(1 Pt 1):241-9.

PMID:
9914611
19.

OC practice guidelines: minimizing side effects.

Darney PD.

Int J Fertil Womens Med. 1997;Suppl 1:158-69. Review.

PMID:
9168375
20.

Oral contraceptives, clotting factors, and thrombosis.

Meade TW.

Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):758-61.

PMID:
6801980
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk